Endometriosis, one of the most frequent diseases in gynecology, is a benign but invasive and metastatic disease. The altered expression of E-cadherin may play an important role in developing endometriosis. In this paper, we discuss the association of three single nucleotide polymorphisms (SNPs) on the E-cadherin gene and risk of endometriosis. We examined the genotype frequency of three polymorphisms in 152 endometriosis patients and 189 control women. There was a significant difference in the frequency of the E-cadherin 3 0 -UTR C/T genotypes between endometriosis and controls (PZ0.01). The frequency of the C allele in patients (71.1%) was significantly higher than in the controls (63.8%; PZ0.04). When compared with the T/TCT/C genotypes, the C/C genotype had a significantly increased susceptibility to endometriosis, with an adjusted odds ratio of 1.79 (95% confidence intervalZ1.17-2.76). No significant difference was found between endometriosis and control women on two polymorphisms (K160 C/A, K347 G/GA) at the gene promoter region of E-cadherin. The K160 C/A and K347 G/GA polymorphisms displayed linkage disequilibrium (D 0 Z0.999). The K160 A/K347 GA haplotype was only detected in endometriosis patients (2%). These data show a relation between the E-cadherin 3 0 -UTR C/T polymorphism, the K160 A/K347 GA haplotype of two promoter polymorphisms and risk of endometriosis, suggesting a potential role in endometriosis development, at least in North Chinese women.
Introduction
Endometriosis is one of the most frequent diseases in gynecology. The etiology and pathogenesis of this disease, defined as the ectopic location of endometrium-like glandular epithelium and stroma outside the uterine cavity, is unclear to date. Clinical observations have led to the assessment that endometriosis is benign gynecologically, but an invasive disease (Spuijbroek et al. 1992 , Foidart et al. 1993 . In vitro experiments also imply that endometriotic cells are invasive and able to metastasize. Analogous to tumor metastasis, it is likely that cell adhesion molecules are central for the invasion and metastasis of endometriotic cells.
Cadherins are a family of adhesion molecules that mediate Ca 2C -dependent cell-cell adhesion in all solid tissues of an organism and modulate a wide variety of processes, including cell polarization and migration (Takeichi 1987 , 1990 , Wheelock & Johnson 2003 ). E-cadherin, an epithelial cellular junction protein expressed in almost all epithelial cells (Shimoyama et al. 1989) , is among the best understood of the cadherins and plays an important role in the maintenance of epithelial development, organization, and cell integrity. The loss of E-cadherin, a metastasis suppressor molecule in carcinomas, is associated with tumor progression and metastases formation in a series of different cancers (Frixen et al. 1991 , Birchmeier & Behrens 1994 , Huiping et al. 2001 , Yoshida et al. 2001 . Is it possible that E-cadherin could also act as an invasion-suppressor molecule in endometriosis? Indeed, primary cells from human endometriotic biopsies but not from human endometrial biopsies were invasive in an in vitro collagen invasion assay. These in vitro invasive endometriotic cells were found to be nonmalignant epithelial cells lacking E-cadherin (Gaetje et al. 1997) .
Moreover, E-cadherin was slightly reduced in eutopic endometrium and significantly decreased in ectopic biopsies of endometriosis patients as compared with that in eutopic endometrium of unaffected women (Starzinski-Powitz et al. 1999 , Poncelet et al. 2002 . Therefore, the loss of E-cadherin expression may constitute a crucial mechanism in the pathogenesis of endometriosis.
The E-cadherin gene is polymorphic; two adjacent SNPs (K160 C/A and K347 G/GA) at upstream positions from the transcriptional start site of the promoter and a single base change from C to T at position C54 after the stop codon of the gene were identified (Becker et al. 1995 , Li et al. 2002 , Nakamura et al. 2002 . These polymorphisms were associated with the development and progression of a certain cancer (Verhage et al. 2002 , Shin et al. 2004a , Wu et al. 2005 . The relation between E-cadherin gene polymorphisms and the risk of developing endometriosis has not been reported. In this paper, we studied three polymorphisms (K160 C/A, K347 G/GA, and 3 0 -UTR C54 C/T) in the E-cadherin gene in association with the risk of developing endometriosis, in North China.
Materials and Methods

Study participants
Blood was obtained from the following two groups and DNA was extracted for genotyping: (p) healthy female blood donors aged 25-51 years (nZ189) and (q) in patients for endometriosis in the Fourth Hospital, Hebei Medical University between 2001 and 2005 (nZ152) . The patients were all clinically, endoscopically, and histologically confirmed. All of the endometriosis patients who had not undertaken treatment with hormones were in stages III and IV. Patients were staged according to the revised American Fertility Society (1985) classification. General information on all patients was recorded in detail in the medical chart.
The control group consisted of women of reproductive age without any malignant disease, which was confirmed by surgical exploration at voluntary abortion, cesarean section, or pathologically after hysterectomy was performed for dysfunctional uterine bleeding. The general information on the healthy controls was extracted from their medical chart. All of the subjects were women of the Han nationality in North China. The Ethics Committee of Hebei Obstetrics and Gynecology Institute approved the study and informed consent was obtained from all recruited subjects.
DNA extraction
Venous blood (5 ml) was drawn from each subject into Vacutainer tubes containing EDTA and stored at 4 8C. Genomic DNA was extracted within 1 week after sampling using proteinase K (Merck) digestion followed by a salting out procedure according to the method of Miller et al. (1988) . E-cadherin K160 C/A, K347 G/GA, and 3 0 -UTR C/T genotyping The E-cadherin K160 C/A, K347 G/GA, and C54 C/T genotypes were determined by PCR-restriction fragment length polymorphism assay. The primers for amplifying the E-cadherin promoter fragment were 5 0 -CGCCCCGACTTGTCTCTCTAC-3 0 (forward) and 5 0 -GGCCACAGCCAATCA GCA-3 0 (backward) and for the C54 C/T SNP at the E-cadherin 3 0 UTR were 5 0 -CAGACAAAGACCAGGACTAT-3 0 (forward) and 5 0 -AAGGGAGCTGA AAAACCACCAGC-3 0 (backward). The PCR was performed in a 25 ml volume containing 100 ng DNA template, 2.5 ml of 10! PCR buffer, 1.5 ml of 25 mmol/l MgCl 2 , 2.5 U Taq DNA polymerase (BioDev-Tech., Beijing, China), 0.5 ml of 10 mmol/l dNTPs, and 200 nM each primer. The PCR cycling conditions were 5 min at 94 8C followed by 35 cycles of 30 s at 94 8C, 30 s at 66 8C for C-160 A and G-347 GA, 30 s at 56 8C for C54 C/T, and 60 s at 72 8C, with a final step at 72 8C for 10 min to allow for the complete extension of all PCR fragments. The PCR product was 448 bp for the E-cadherin promoter and two 8 ml aliquots were subjected to digestion at 37 8C overnight in a 10 ml reaction containing 10 U HincII (SBS Genetech Co. Ltd, Beijing, China) or 10 U BanII (TakaRa Biotechnology Co. Ltd, Dalian, China). After digestion, the products were separated on a 3% agarose gel that was stained with ethidium bromide. For the K160 C/A polymorphism, the A alleles were represented by DNA bands with sizes of 368 and 80 bp and the C alleles were represented by a DNA band with a size of 448 bp, whereas the heterozygotes displayed a combination of both alleles (448, 368, and 80 bp; Fig. 1 ). For the K347 G/GA polymorphism, the GA alleles were represented by DNA bands with sizes of 332 and 116 bp and the G alleles were represented by a DNA band with sizes of 263, 116, and 68 bp, whereas the heterozygotes displayed a combination of both alleles (332, 263, 116, and 68 bp; Fig. 2) . The PCR product of the 3 0 -UTR C/T polymorphism in the E-cadherin 3 0 UTR was 172 bp. After digestion by PmacI (TakaRa Biotechnology Co. Ltd), the products were separated on a 3% agarose gel that was stained with ethidium bromide. As a result, the 3 0 -UTR T alleles were represented by a DNA band with a
Figure 1 E-cadherin K160 bp C/A genotyping by PCR-RFLP analysis followed by separation on 3% agarose gel as described in the text. Lane MZ100 bp ladder; lanes 2, 3, and 6ZC/C; lanes 1 and 5ZC/A; lanes 4 and 7ZA/A.
size of 172 bp and the 3 0 -UTR C alleles were represented by DNA bands with sizes of 146 and 26 bp, whereas the heterozygotes displayed a combination of both alleles (172, 146, and 26 bp; Fig. 3 ).
For a negative control, distilled water was used instead of DNA in the reaction system for each panel of PCR. The PCRs of 10% of the samples were run in duplicate for quality control.
Statistical analysis
Statistical analysis was performed using the SPSS10.0 software package (SPSS Inc., Chicago, IL, USA). HardyWeinberg analysis was performed to compare the observed and expected genotype frequencies using the c 2 test. A comparison of the E-cadherin K160 C/A, K347 G/GA, and 3 0 -UTR C/T genotype distributions in the study groups was performed by means of twosided contingency tables using the c 2 test. The E-cadherin K160 C/A and K347 G/GA haplotype frequencies and linkage disequilibrium coefficients were estimated using the EH linkage software (version 1.2, Rockefeller University, New York, NY, USA). The odds ratio (OR) and 95% confidence interval (CI) were calculated using an unconditional logistic regression model and adjusted by age accordingly. A probability level of 5% was considered significant.
Results
Association of E-cadherin K160 C/A, K347 G/GA, and 3
0 -UTR C/T SNP with susceptibility to endometriosis
The distribution of the E-cadherin K160 C/A, K347 G/GA, and 3 0 -UTR C/T genotypes in the control group did not significantly deviate from that expected for a Hardy-Weinberg equilibrium (c 2 Z0.33, 0.14, and 2.65 respectively and PZ0.57, 0.70, and 0.10 respectively). There was no significant difference in genotype and allelotype distribution of the E-cadherin K160 C/ A SNP between endometriosis patients and controls (Table 1 , all P values 0.05). When compared with the C/ C genotype, the carriers of the 'A' allele were not significantly susceptible to developing endometriosis. The OR was 0.82 (95% CIZ0.52-1.29; Table 2 ).
The frequencies of the three genotypes and two allelotypes of E-cadherin K347 G/GA in endometriosis patients were not different from those in controls (Table 1 , all P values O0.05). When compared with the G/G genotype, the G/GACGA/GA genotypes did not significantly influence the risk of developing endometriosis. The OR was 1.20 (95% CIZ0.78-1.84; Table 2 ).
There were significant differences in genotype and allelotype distribution of the E-cadherin 3 0 -UTR C/T between endometriosis patients and controls (Table 1, all P values !0.05). The distribution of the C/C genotype in endometriosis patients (57.9%) was higher than that in the controls (43.4%). When compared with the T/TCC/T genotypes, the C/C genotype significantly increased the risk of development of endometriosis. The OR was 1.79 (95% CIZ1.17-2.76; Table 2 ).
Figure 2 E-cadherin K347 bp G/GA genotyping by PCR-RFLP analysis followed by separation on 3% agarose gel as described in the text. Lane MZ100 bp ladder; lanes 3 and 5ZGA/GA; lanes 1 and 7ZG/GA; lanes 2 and 6ZG/G; lane 4ZPCR product.
Figure 3 E-cadherin 3
0 -UTR C/T genotyping by PCR-RFLP analysis followed by separation on 3% agarose gel as described in the text. Lane MZ100 bp ladder; lane 2ZT/T; lanes 3 and 4ZC/T; lanes 5 and 6ZC/C; lane 1ZPCR product. Haplotype of E-cadherin K160 C/A and K347 G/ GA, two SNPs with susceptibility to endometriosis
The results of the 2LD program analysis showed that the E-cadherin K160 C/A and K347 G/GA polymorphisms displayed linkage disequilibrium (D 0 Z0.999). The K160 C/K347 G was the most common haplotype in the control women (56.4%), followed by the K160 C/K347 GA (24.0%) and K160 A/K347G (19.6%) haplotypes. The K160 A/K347 GA haplotype was only detected in endometriosis patients (2%). When compared with the most common haplotype of K160 C/K347 G, the haplotypes of K160 C/K347 GA and K160 A/K347 G were not significantly indicative of the risk of endometriosis (Table 3) .
Discussion
In the present study, we focused on the significance of E-cadherin polymorphisms to the risk of developing endometriosis. The results showed that there is no association between the K160 C/A and K347 G/ GA polymorphisms at the E-cadherin gene promoter region and the risk of developing endometriosis. However, the haplotype of K160 C/K347 GA and the 3 0 -UTR C/T polymorphism of the E-cadherin gene were associated with the risk of endometriosis. The K160 C/K347 GA haplotype and 3 0 -UTR C/C homozygote indicated a relatively higher risk for developing endometriosis than other genotypes.
The K160 C/A and K347 G/GA are two common SNPs upstream from the transcriptional start site of the E-cadherin gene and have a significant effect on the transcriptional activity in transient transfection studies. Several major cis-acting elements have been identified within a short section of the proximal promoter. Among these are the two E boxes, a CAAT box and a SP1-binding site (Giroldi et al. 1997) . The E-cadherin gene promoter thus exhibits a modular structure, suggesting that the strict control of epithelium-specific E-cadherin expression might result from interactions among the various regulatory elements (Behrens et al. 1991) . Therefore, the molecular mechanism of differential transcriptional activity may be well explained as a difference in affinity of the DNAbinding protein(s) to the two allelic forms of the E-cadherin promoter. The 'A' allele of the K160 C/A polymorphism decreased the transcriptional efficiency by 68% when compared with the C allele (Li et al. 2002) . The 'GA' allele of the K347 G/GA polymorphism decreased the transcriptional efficiency by tenfold when compared with the 'G' allele (Shin et al. 2004a) . The K160 C/A and K347 G/GA allelic variation may be a potential genetic marker that can help identify individuals at a higher risk for invasive/metastatic diseases.
Recently, studies have investigated the association between the E-cadherin K160 C/A polymorphism and the risk of several types of cancer but the results were mixed. Verhage et al. (2002) found that 'A' allele carriers had a higher risk of prostate cancer when compared with 'C' allele carriers. Jonsson et al. (2004) studied Swedish patients with hereditary prostate cancer and also found a higher risk among 'A' allele carriers. However, there was no association between the E-cadherin K160 C/A polymorphism and the occurrence or progression of prostate cancer in Japanese populations (Tsukino et al. 2004) . In a study of gastric cancer, Park et al. (2003) suggested that the K160 C/A polymorphism of E-cadherin has no direct effect on the risk of development of gastric cancer and its histological classification. However, the Wu et al. (2002) study suggested that individuals with the K160 A/A genotype of E-cadherin have a decreased risk of gastric carcinoma. The E-cadherin K347 G/GA polymorphism has been reported to be associated with risk of developing familial gastric cancer and sporadic colorectal cancers (Shin et al. 2004a (Shin et al. , 2004b . The GA allele may be a risk factor for certain cancers.
In this paper, our study showed that there was no significant difference in the frequencies of the E-cadherin K160 C/A and K347 G/GA polymorphism genotypes between endometriosis and controls. However, the result shows a significant linkage disequilibrium between the K160 C/A and the K347 G/GA The odds ratio of the C/ACA/A genotype against the C/C genotype for K160 C/A polymorphism.
b
The odds ratio of the G/GACGA/GA genotype against the C/C genotype for K347 G/GA polymorphism. The odds ratio of the C/C genotype against the T/TCC/T genotype for 3 0 -UTR C/T polymorphism. The odds ratio of the C/GA haplotype against the C/G haplotype in endometriosis. polymorphisms, i.e. the K160 C allele tended to be linked to the K374 G allele. The K160 C/K374 G was the most common haplotype in healthy women of North China (56.4%). The frequency of the K160 G/K374 GA haplotype was 0% in the control group and 2% in endometriosis patients. The K160 G/K374 GA haplotype may be a risk factor for developing endometriosis because the K160 G and K374 GA alleles were associated with decreased transcriptional efficiency of the E-cadherin gene. However, this result needs to be further tested in larger studies of endometriosis patients.
The C/T polymorphism is located at nucleotide 2797 of the E-cadherin cDNA sequence, 54 nucleotides downstream from the TAG stop codon. Although the function of the 3 0 -UTR C54 C/T polymorphism was unclear, studies have showed that this polymorphism was associated with cancer and other diseases (Tsai et al. 2003 , Wu et al. 2005 , Lin et al. 2006 . Wu et al. found that the 'CC' homozygote indicates a relatively higher risk for developing prostate cancer than other genotypes (Lin et al. 2006) . Our study also showed that the frequency of the 'CC' homozygote in endometriosis patients (57.9%) was higher than that in controls (43.4%) and the 'CC' homozygote carriers had a higher incidence of developing endometriosis (1.79-fold) than those who do not. Our other study was consistent with this paper, which suggested that the 'CC' homozygote was a high risk factor for the development of gastric cardiac adenocarcinoma and ovarian cancer. In addition, the E-cadherin protein expression of ovarian cancer patients with CC genotype was significantly lower than that of the ones with CT or TT genotype (PZ0.017; unpublished results). As we know, the 3 0 -UTR is not the translated area of the protein, but it may be associated with mRNA stability of the transcript. The understanding of the E-cadherin gene 3 0 -UTR is limited. The Keirsebilck et al. (1998) in vitro study revealed that the downregulation of E-cadherin protein expression was caused by mRNA instability that was triggered by particular 3 0 -UTR sequences. Moreover, there are many examples where the 3 0 -UTR may change the expression of genes, such as the TYMS gene that contains a 6 bp deletion/insertion in the 3 0 -UTR that affects the TYMS mRNA stability and translation (Ulrich et al. 2000) . The polymorphism of the 3 0 -UTR in the CYP2A6 gene played an important role in CYP2A6 mRNA stabilization and enzyme expression. Such polymorphisms have been described to influence the in vivo rate of nicotine elimination and possibly the cigarette consumption and risk of smokinginduced lung cancer (Wang et al. 2006 ). Although we are not going to conclude that the 'C' allele of the E-cadherin gene 3 0 -UTR polymorphism is the direct cause of endometriosis, we can indicate that there is an association. These findings suggest that the 3 0 -UTR C/T polymorphism may play a role in the etiology of endometriosis.
The etiology of endometriosis is uncertain, but implantation of viable endometrium refluxed into the peritoneal cavity during menstruation is a major theory (Thomas 1993) . Since retrograde menstruation is a very common phenomenon among women of reproductive age, there must be other factors that contribute to the pathophysiology and/or the pathogenesis of endometriosis. Genetic predisposition is believed to play a significant role in the establishment and maintenance of endometriosis. Whether the differential expression of E-cadherin between eutopic endometrium and ectopic biopsies of endometriosis patients and those of unaffected women is related to genetic factors that are associated with the risk for developing endometriosis is important for understanding the mechanism of endometriosis.
To the best of our knowledge, this is the first study to look for an association between the polymorphisms of the E-cadherin gene and the risk of developing endometriosis. Our study results suggest that certain genetic polymorphisms of the E-cadherin gene seem to be correlated with a risk of developing endometriosis. Further, larger population-based studies as well as functional evaluation of the variants are warranted to confirm our findings.
